Thursday morning brought mixed signals for U.S. stock futures, with the Dow futures edging up around 0.1% while several notable names struggled in pre-market action.
Pre-Market Movers: Snowflake Slides Despite Earnings Beat While Symbotic Tumbles on Share Offering
Get Adc Therapeutics SA Alerts
Weekly insights + SMS alerts
Snowflake's Puzzling Decline
The morning's head-scratcher comes from Snowflake Inc. (SNOW), which is getting hammered despite posting a solid earnings beat. The AI data cloud company delivered third-quarter revenue of $1.21 billion, topping analyst estimates of $1.18 billion. Adjusted earnings came in at 35 cents per share, beating expectations of 31 cents per share.
So why the sell-off? Sometimes beating estimates isn't enough if guidance disappoints or growth rates decelerate, though the market's reaction suggests investors found something less than thrilling in the details. Snowflake shares tumbled 8.6% to $241.85 in pre-market trading.
Other Notable Decliners
Net Lease Office Properties (NLOP) led the decliners, plunging 14.7% to $25.19 in pre-market action. That's a rough morning for the office property REIT.
Symbotic Inc. (SYM) dropped 10.5% to $65.50 after announcing a 10 million share offering. The warehouse automation company plans to sell 6.5 million new shares while a selling stockholder will offload another 3.5 million. Dilution fears are hitting the stock hard.
Capricor Therapeutics Inc. (CAPR) gave back some of Wednesday's massive gains, falling 8.4% to $27.45. This comes after the biotech rocketed 371% higher Wednesday on news that its Phase 3 HOPE-3 trial evaluating deramiocel cell therapy for Duchenne Muscular Dystrophy met its primary endpoint and secondary cardiac endpoint. A pullback after a move like that isn't exactly shocking.
ADC Therapeutics SA (ADCT) declined 8.1% to $3.63, extending Wednesday's 14% drop. The company recently reported updated data from its LOTIS-7 trial evaluating Zynlonta in combination with Glofitamab in relapsed/refractory DLBCL patients, and the market's reaction suggests the data didn't impress.
Rounding out the decliners: Lineage Cell Therapeutics Inc. (LCTX) fell 7.1% to $1.56, Koninklijke Philips NV (PHG) dropped 6.8% to $26.11, Omeros Corp. (OMER) declined 4.2% to $10.18, and Methanex Corp. (MEOH) slipped 3.8% to $35.95 in pre-market trading.
More News

Trump Warns Iran of Economic Collapse or Worse, Tehran Threatens US Bases as Brent Sits at $102

Trump Wants to Rename AI Because 'Artificial Intelligence' Is 'Very Ineloquent' — And He's Letting the Internet Vote

Elizabeth Warren Says 'We Will Win in November' — What Crypto Bettors Think About Democrats' Midterm Odds

US-Greenland Deal Opens a Rare Earth Frontier, But the Arctic Doesn't Do Easy

Hakeem Jeffries Torches Trump and Republicans Over Rising Gas, Grocery, Housing and Health Costs: 'America Is Way Too Expensive'

Elissa Slotkin Calls for 'Legal, Vetted Immigrants' to Help US Economy: 'We're Getting Older'

Sanders, Pelosi and Newsom Blast Trump's White House Press Ban: 'We Will Not Accept Authoritarianism'

Macron Meets Carney Amid Trump Map Row, Sanders Slams Trump's Ban On Reporters and More: This Week in Politics
Get Adc Therapeutics SA Alerts
Real-time alerts on price moves, news, and trading opportunities.
Join 20,000+ investors. No spam, ever.
Featured Articles
View all news
Trump Warns Iran of Economic Collapse or Worse, Tehran Threatens US Bases as Brent Sits at $102

He Found Rolls-Royce Below $2. Now He’s Found His Second Unicorn. (Ad)

Trump Wants to Rename AI Because 'Artificial Intelligence' Is 'Very Ineloquent' — And He's Letting the Internet Vote

Elizabeth Warren Says 'We Will Win in November' — What Crypto Bettors Think About Democrats' Midterm Odds

US-Greenland Deal Opens a Rare Earth Frontier, But the Arctic Doesn't Do Easy

Hakeem Jeffries Torches Trump and Republicans Over Rising Gas, Grocery, Housing and Health Costs: 'America Is Way Too Expensive'

Elissa Slotkin Calls for 'Legal, Vetted Immigrants' to Help US Economy: 'We're Getting Older'






